U.K. Ai In Oncology Market Size & Outlook, 2026-2033
- Healthcare IT
- AI in Healthcare
- AI In Oncology Market Outlook
- AI in Healthcare
Global Market
Related Markets
Ask Prism AI about the ai in oncology market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
UK ai in oncology market highlights
- The UK ai in oncology market generated a revenue of USD 240.4 million in 2025 and is expected to reach USD 1,533.3 million by 2033.
- The UK market is expected to grow at a CAGR of 24.5% from 2026 to 2033.
- In terms of segment, hardware was the largest revenue generating component in 2025.
- Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
Ai in oncology market data book summary
| Market revenue in 2025 | USD 240.4 million |
| Market revenue in 2033 | USD 1,533.3 million |
| Growth rate | 24.5% (CAGR from 2026 to 2033) |
| Largest segment | Hardware |
| Fastest growing segment | Software Solutions |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hardware, Software Solutions, Services |
| Key market players worldwide | International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp |
Other key industry trends
- In terms of revenue, UK accounted for 4.0% of the global ai in oncology market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany ai in oncology market is projected to lead the regional market in terms of revenue in 2033.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 1,178.4 million by 2033.
The AI in oncology market in the UK is propelled by several key factors. One significant driver is the adoption of AI technologies by the National Health Service (NHS) and healthcare specialists. This adoption aims to enhance the diagnostic capabilities in oncology, offering more accurate and efficient methods for disease detection and assessment.
Additionally, market players are actively engaging in business initiatives to contribute to the growth of AI in oncology. These initiatives involve the development and deployment of AI solutions tailored to address specific challenges in oncological diagnosis and treatment, further contributing to the advancement of healthcare practices in the UK.
No credit card required*
Publish Date: Dec 16, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Oncology Market Scope
AI In Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Intel Corp | View profile | 124,800 | 2200 Mission College Boulevard, Santa Clara, CA, United States, 95054-1549 | www.intel.com |
| International Business Machines Corp | View profile | 282,200 | One New Orchard Road, Armonk, NY, United States, 10504 | www.ibm.com |
| NVIDIA Corp | View profile | 29,600 | 2788 San Tomas Expressway, Santa Clara, CA, United States, 95051 | www.nvidia.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
U.K. AI In Oncology Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to AI In Oncology Market Outlook will help companies and investors design strategic landscapes.
Hardware was the largest segment with a revenue share of 54.58% in 2025.
Horizon Databook has segmented the U.K. ai in oncology market based on hardware, software solutions, services covering the revenue growth of each sub-segment from 2021 to 2033.
The AI in oncology market in the UK is propelled by several key factors. One significant driver is the adoption of AI technologies by the National Health Service (NHS) and healthcare specialists. This adoption aims to enhance the diagnostic capabilities in oncology, offering more accurate and efficient methods for disease detection and assessment.
Additionally, market players are actively engaging in business initiatives to contribute to the growth of AI in oncology. These initiatives involve the development and deployment of AI solutions tailored to address specific challenges in oncological diagnosis and treatment, further contributing to the advancement of healthcare practices in the UK.
- U.K. Ai In Oncology Market Component Outlook (Revenue, USD Million , 2021-2033)
- Hardware
- Software Solutions
- Services
- U.K. Ai In Oncology Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumour
- Others
- U.K. Ai In Oncology Market Application Outlook (Revenue, USD Million , 2021-2033)
- Diagnostics (Pathology, Cancer Radiology)
- Radiation therapy (Radiotherapy)
- Research & Development (Drug design, development process, etc.)
- Chemotherapy
- Immunotherapy
- U.K. Ai In Oncology Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Surgical Centers & Medical Institutes
- Others (Pharmaceutical companies, Research institutes & training centers)
Reasons to subscribe to AI In Oncology Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of AI In Oncology Market Outlook databook
- Our clientele includes a mix of AI In Oncology Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. AI In Oncology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. AI In Oncology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.K. Ai In Oncology Market, 2021-2033 (US$M)
UK ai in oncology market statistics, by component, 2021-2033 (US$M)
